Bacil Pharma Fair Value
Bacil Pharma (BACPHAR) average fair value is ₹27.79 across 4 valuation models — P/E Based Valuation, P/B Based Valuation, Asset-Based Valuation, Benjamin Graham Number, vs a current market price of ₹39.38 (-29.42%), fair value range ₹17.86–₹49.11.
Fair Value Analysis Export
BACPHAR Fair Value vs Current Price — Valuation Summary
BACPHAR average fair value, fair value range, price gap and valuation status across 4 models: P/E Based Valuation, P/B Based Valuation, Asset-Based Valuation, Benjamin Graham Number. Check BACPHAR market capitalization to track the company's total market size over time.
P/E Based Valuation
P/B Based Valuation
Asset-Based Valuation
Benjamin Graham Number
BACPHAR Fair Value Analysis — Data Sources & Coverage
Bacil Pharma financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year. For live price and a broader fundamental view, visit Bacil Pharma share price today.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Data Currency: Financial data is from the current year (2026).
BACPHAR vs Healthcare Sector Peers — P/E, P/B & Market Cap
Bacil Pharma P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | 0.2 | ₹41 |
| Jeena Sikho Lifecare | JSLL | 33.24 | 15.78 | ₹7,371 |
| Sat Kartar Life | SATKARTAR | 13.44 | 3.4 | ₹226 |
| KRM Ayurveda | KRMAYURVED | - | 4.56 | ₹545 |
| Emcure Pharmaceuticals | EMCURE | 37.24 | 7.08 | ₹34,821 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.